Measles re-emerging globally

Measles is a common childhood illness but can cause more than a passing fever with rash. It could turn out to be a complicated and severe illness, warn doctors in a new paper published in February 2020 in the journal BMJ Case Reports.

Measles

Measles is a very contagious viral illness caused by a respiratory virus. It can cause fever, cough, conjunctivitis, or reddening of the eyes, with a rash found all over the body. It also causes severe immunosuppression in some patients, which results in secondary bacterial infection of the lung, or in viral hepatitis, meningitis, and appendicitis.

Measles rash. Image Credit: Phichet Chaiyabin / Shutterstock
Measles rash. Image Credit: Phichet Chaiyabin / Shutterstock

The good thing about measles is that a very effective and safe vaccine can prevent it. However, the acceptance of this vaccine and the related MMR (mumps, measles, and rubella) vaccine has gone down in recent decades because of largely baseless fears that it causes autism in children. Several extensive well-conducted studies have disproved this accusation, but people are still not willing to believe the results. The drop in vaccination rates means a decline in the number of people who receive the measles vaccine and in herd immunity (the population-level immunity that protects unimmunized people from an infection because of the low infection rate in other immunized people around them.  As a result, measles has made a significant comeback in many countries around the world, especially in teens and adults.

In 2017, over 110,000 children died of this preventable disease, of whom most were very young. The authors point out, “Large outbreaks with fatalities are currently ongoing in European countries which had previously eliminated or interrupted endemic transmission.” About 10,000 new cases occurred in Europe alone in the period January to June 2019, and most were in adults aged 20-45 years.

The report

The new case report series deals with three people with measles who developed additional complications. For instance, the first was a young man who was only partially immunized against measles, with one dose in childhood instead of two. He developed hepatitis, or liver inflammation, as well.

In the second case, a young woman developed appendicitis in addition to measles. And in the last case report, a middle-aged patient with measles later developed viral meningitis, diagnosed after he reported blurring of vision and a bad headache.

The implications

In all cases, the patients were given proper care and treated with the appropriate tools. All recovered without lasting sequelae.

However, these occurrences are far from unique. In almost 1 of 3 cases, the disease is complicated by another illness, which can involve any organ of the body. This could include pneumonia, seizures caused by high temperatures, and encephalomyelitis, which refers to inflammation of the brain and spinal cord. The patients could have neurological sequelae as a result of these complications.

Another known though rare complication of measles is subacute sclerosing panencephalitis (SSPE), in which the nervous system undergoes progressive damage, finally leaving the affected person to live like a vegetable.

The Centers for Disease Control and Prevention (CDC) report that most complications in measles today occur in children below 5 and adults over 20 years of age, as well as pregnant women and those with weakened immunity. The most common complications requiring intensive care include pneumonia, but post-infectious encephalomyelitis comes a close second.

These complications hit almost every system in the body because the virus is capable of infecting epithelial, reticuloendothelial, and white blood cells, resulting in a severe loss of immunity. In fact, the observed decline in CD4 lymphocytes begins before the rash appears and lasts for as long as one month.

The authors conclude, “Urgent efforts are needed to ensure global coverage with two-dose measles vaccines through education and strengthening of national immunization systems.”

Journal reference:

Xerri T, Darmanin N, Zammit MA, et alComplications of measles: a case series, BMJ Case Reports CP 2020;13:e232408. https://casereports.bmj.com/content/13/2/e232408

Dr. Liji Thomas

Written by

Dr. Liji Thomas

Dr. Liji Thomas is an OB-GYN, who graduated from the Government Medical College, University of Calicut, Kerala, in 2001. Liji practiced as a full-time consultant in obstetrics/gynecology in a private hospital for a few years following her graduation. She has counseled hundreds of patients facing issues from pregnancy-related problems and infertility, and has been in charge of over 2,000 deliveries, striving always to achieve a normal delivery rather than operative.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, Liji. (2020, February 17). Measles re-emerging globally. News-Medical. Retrieved on December 04, 2024 from https://www.news-medical.net/news/20200217/Measles-re-emerging-globally.aspx.

  • MLA

    Thomas, Liji. "Measles re-emerging globally". News-Medical. 04 December 2024. <https://www.news-medical.net/news/20200217/Measles-re-emerging-globally.aspx>.

  • Chicago

    Thomas, Liji. "Measles re-emerging globally". News-Medical. https://www.news-medical.net/news/20200217/Measles-re-emerging-globally.aspx. (accessed December 04, 2024).

  • Harvard

    Thomas, Liji. 2020. Measles re-emerging globally. News-Medical, viewed 04 December 2024, https://www.news-medical.net/news/20200217/Measles-re-emerging-globally.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study shows gradual waning of MMR vaccine effectiveness over time